DESKi is thrilled to announce that we have successfully raised €6,000,000 in our latest funding round, marking a significant milestone in our journey toward revolutionizing heart care. With our headquarters based in Bordeaux, France, our diverse international team is driven by a singular, passionate vision: to create a smarter path to heart exams for all and take on the world’s #1 killer, heart disease. At the core of our innovation is HeartFocus, our groundbreaking AI-powered software introduced in 2023, which empowers any healthcare professional to perform highly precise heart exams, regardless of location. This cutting-edge technology is designed not only to enhance diagnostic accuracy but also to democratize access to critical cardiovascular assessments, ensuring that no heart can wait.
The funds secured in this round will be strategically invested in further advancing the development of HeartFocus, expanding its capabilities, and exploring new applications that bridge the gap between technology and patient care. We plan to extend our reach into emerging markets, enhance the software’s robustness through ongoing AI research, and strengthen support frameworks that guarantee seamless integration with existing healthcare systems. This infusion of capital is a testament to the trust our investors have in our mission and our audacious team, whose commitment continues to drive the evolution of heart diagnostics. As DESKi continues to push the boundaries of what is possible with AI and digital health, we remain devoted to our philosophy—No heart can wait™—ensuring that every heart exam is as accurate and accessible as possible for the sake of a healthier future.
